Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Acute Lymphoblastic Leukemia Registry at Asan Medical Center
The Acute Lymphoblastic Leukemia Registry trial at Asan Medical Center has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia (2015)
A clinical trial evaluating allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL) [Phase 2]
A Phase 2 study evaluating JCAR015 in adult B-cell acute lymphoblastic leukemia has been terminated; results are posted but no efficacy conc…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
This Clinical Trial Update describes a study collecting and storing malignant and related samples from young cancer patients; the trial stat…
-
FDA approval · 2018-07-17FDA Approved: CYTARABINE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approves the original application for CYTARABINE (cytarabine) from Meitheal Pharmaceuticals Inc., making a generic cytarabine product av…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-07-13Clinical Trial Update: Creating a Decision Support System for the Corporate Management of Physical Therapy
A clinical trial update describing development of a decision support system to manage physical therapy for pediatric cancer patients, includ…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 3]
Phase 3 trial update on combination chemotherapy for newly diagnosed acute lymphoblastic leukemia in young patients, with completed status a…
-
CLINICAL_TRIALS research · 2018-07-06Clinical Trial Update: Evaluation of the Interest of a Specialist in Dermatology for Dermatopediatric Consultations
A clinical trial update evaluating the interest of a dermatology specialist for dermatopediatric consultations; sponsor is Central Hospital,…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Improving Blood Stem Cell Collection and Transplant Procedures [Phase 1, Phase 2]
Phase 1/2 clinical trial update focused on improving blood stem cell collection and transplant procedures, completed with results reported b…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation [Phase 1]
Phase 1 trial update reporting completion of a study evaluating ultra-low-dose interleukin-2 as graft-versus-host disease prophylaxis in hap…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL [Phase 1]
Phase 1 trial of Eryaspase (L-asparaginase encapsulated in red blood cells) for adult acute lymphoblastic leukemia or lymphoblastic lymphoma…
-
CLINICAL_TRIALS research · 2018-07-02Clinical Trial Update: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer [NA]
Clinical trial update on caregiver-delivered massage therapy to improve quality of life in pediatric cancer patients; the study (NCT01053494…
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial update exploring dose escalation of cladribine in conditioning regimens before allogeneic stem cell transplantation for refr…
-
CLINICAL_TRIALS research · 2018-06-21Clinical Trial Update: Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL [Phase 2, Phase 3]
Clinical trial update for chidamide-based targeted therapy in adult T-cell lymphoblastic leukemia/lymphoma (T-LBL/ALL), spanning Phase 2 and…
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial update on GRASPA (erythrocyte-encapsulated L-asparaginase) in elderly patients with first-line acute lymphoblastic leukemia; r…
-
CLINICAL_TRIALS research · 2018-06-12Clinical Trial Update: Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating chidamide, an HDAC inhibitor, as targeted therapy for adult early T-cell precursor acute lympho…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]
A phase 2 study of augmented Berlin-Frankfurt-Munster therapy with ofatumumab in young adults with acute lymphoblastic leukemia or lymphobla…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Chronic Pain After Scoliosis and Thoracic Surgery in Children
This update indicates that the pediatric clinical trial evaluating chronic pain after scoliosis surgery and thoracic surgery has completed. …
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
The National Cancer Institute-sponsored clinical trial assessing relapse in malignant blood cancers after allogeneic hematopoietic stem cell…
-
CLINICAL_TRIALS research · 2018-06-04Clinical Trial Update: CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL） [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CART-19, a CD19-targeted CAR-T cell therapy, for relapsed or refractory acute lymphoblastic leukemia; …
-
FDA approval · 2018-05-29FDA Approved: ICLUSIG — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ICLUSIG (ponatinib hydrochloride) filed by Takeda Pharmaceuticals America, Inc., marking a r…
-
FDA approval · 2018-05-23FDA Approved: MERCAPTOPURINE — Supplemental Application (Florida Pharmaceutical Products, LLC)
The FDA approved a supplemental application for mercaptopurine from Florida Pharmaceutical Products, LLC.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]
A Phase 1/2 trial of CD19-CAR immunotherapy for childhood acute lymphoblastic leukemia has been terminated.
-
CLINICAL_TRIALS research · 2018-05-09Clinical Trial Update: Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction [Phase 2, Phase 3]
This clinical trial update discusses the Phase 2/Phase 3 evaluation of pentoxifylline in pediatric patients undergoing induction therapy for…
-
CLINICAL_TRIALS research · 2018-05-08Clinical Trial Update: ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients [NA]
ALL-Active is a family-based lifestyle program for pediatric acute lymphoblastic leukemia patients in remission; this update notes the trial…